These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 2536817

  • 1. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
    Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson AB.
    J Virol; 1989 Mar; 63(3):1031-9. PubMed ID: 2536817
    [Abstract] [Full Text] [Related]

  • 2. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
    Maunders MJ, Petti L, Rowe M.
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
    [Abstract] [Full Text] [Related]

  • 3. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Chen A, Zhao B, Kieff E, Aster JC, Wang F.
    J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
    [Abstract] [Full Text] [Related]

  • 4. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG.
    Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5862-6. PubMed ID: 1321426
    [Abstract] [Full Text] [Related]

  • 5. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
    Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E.
    Proc Natl Acad Sci U S A; 1990 Apr 01; 87(8):2906-10. PubMed ID: 2158098
    [Abstract] [Full Text] [Related]

  • 6. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection.
    Buisson M, Morand P, Genoulaz O, Bourgeat MJ, Micoud M, Seigneurin JM.
    J Gen Virol; 1994 Feb 01; 75 ( Pt 2)():431-7. PubMed ID: 8113767
    [Abstract] [Full Text] [Related]

  • 7. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers.
    Yao QY, Rowe M, Martin B, Young LS, Rickinson AB.
    J Gen Virol; 1991 Jul 01; 72 ( Pt 7)():1579-90. PubMed ID: 1649896
    [Abstract] [Full Text] [Related]

  • 8. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
    Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB.
    J Exp Med; 1992 Jul 01; 176(1):157-68. PubMed ID: 1319456
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
    Finke J, Rowe M, Kallin B, Ernberg I, Rosén A, Dillner J, Klein G.
    J Virol; 1987 Dec 01; 61(12):3870-8. PubMed ID: 2824821
    [Abstract] [Full Text] [Related]

  • 10. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
    Sample C, Parker B.
    Virology; 1994 Dec 01; 205(2):534-9. PubMed ID: 7975254
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
    Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E.
    J Virol; 1990 Sep 01; 64(9):4084-92. PubMed ID: 2166806
    [Abstract] [Full Text] [Related]

  • 12. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
    Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB.
    J Gen Virol; 1987 Nov 01; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
    [Abstract] [Full Text] [Related]

  • 13. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ.
    J Exp Med; 1992 Jul 01; 176(1):169-76. PubMed ID: 1377222
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
    Tomkinson B, Robertson E, Kieff E.
    J Virol; 1993 Apr 01; 67(4):2014-25. PubMed ID: 8445720
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB.
    J Gen Virol; 1988 May 01; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
    [Abstract] [Full Text] [Related]

  • 16. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.
    Rickinson AB, Young LS, Rowe M.
    J Virol; 1987 May 01; 61(5):1310-7. PubMed ID: 3033261
    [Abstract] [Full Text] [Related]

  • 17. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN, Stewart JP, Janjua NJ, Pepper SD, Sample C, Rooney CM, Arrand JR.
    Virology; 1995 Apr 20; 208(2):521-30. PubMed ID: 7538250
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Cohen JI, Wang F, Mannick J, Kieff E.
    Proc Natl Acad Sci U S A; 1989 Dec 20; 86(23):9558-62. PubMed ID: 2556717
    [Abstract] [Full Text] [Related]

  • 19. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
    Jiang H, Cho YG, Wang F.
    J Virol; 2000 Jul 20; 74(13):5921-32. PubMed ID: 10846073
    [Abstract] [Full Text] [Related]

  • 20. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice.
    Tang Y, Lu S, Gan X, Liu F, Zhang Y, Luo C, Pan Y, Hong L, Gan R.
    Oncol Rep; 2016 Feb 20; 35(2):905-11. PubMed ID: 26548532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.